Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters

CompletedOBSERVATIONAL
Enrollment

3,148

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2008

Conditions
Hypertension
Trial Locations (17)

Unknown

Boehringer Ingelheim Investigator Site, Changhua

Boehringer Ingelheim Investigator Site 1, Chiayi City

Boehringer Ingelheim Investigator Site 2, Chiayi City

Boehringer Ingelheim Investigator Site, Keelung

Boehringer Ingelheim Investigator Site, Ksohsiung

Boehringer Ingelheim Investigator Site, Miaoli

Boehringer Ingelheim Investigator Site 1, Taichung

Boehringer Ingelheim Investigator Site 2, Taichung

Boehringer Ingelheim Investigator Site 1, Tainan City

Boehringer Ingelheim Investigator Site 2, Tainan City

Boehringer Ingelheim Investigator Site 1, Taipei

Boehringer Ingelheim Investigator Site 2, Taipei

Boehringer Ingelheim Investigator Site 3, Taipei

Boehringer Ingelheim Investigator Site 4, Taipei

Boehringer Ingelheim Investigator Site 5, Taipei

Boehringer Ingelheim Investigator Site 6, Taipei

Boehringer Ingelheim Investigator Site 7, Taipei

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00615108 - Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters | Biotech Hunter | Biotech Hunter